Fundraising FoxVaxinnate
Cranbury, US · Delaware corporation · 3 known investors
Find your way into Vaxinnate
Sign up to see every warm intro you have to Vaxinnate
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vaxinnate team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
WP
Wayne PisanoExecutive
LT
Lynda TusseyExecutive
KA
Kathleen A. McGowanExecutive
AR
Alan R. ShawExecutive
AT
Andrew T. DrechslerExecutive
Board
PO
Philippe O. ChambonBoard director
DW
David WilliamsBoard director
SW
Sam WuBoard director
AL
TS
Timothy ShannonBoard director
SR
Seth RudnickBoard director
TM
Thomas MonathBoard director
Investors · 3
Saints Capitallisted by Saints CapitalDenver
How we know: Saints Capital's portfolio page · Not right? Tell us
Canaan PartnersreportedStamford · $500K – $20M
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$34.1M disclosed across 3 rounds · 2010–2015
▶$3.2MraisedSep 2015 · 14 investors · BiotechnologyRule 506(b)
▶$3.2MraisedSep 2015 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philippe O. ChambonDirector
- Thomas MonathDirector
- Wayne PisanoExecutive Officer, Director
- David WilliamsDirector
- Sam WuDirector
- Augustine LawlorDirector
- Lynda TusseyExecutive Officer
- Kathleen A. McGowanExecutive Officer
- Timothy ShannonDirector
- Offering amount
- $4.3M
- Amount sold
- $3.2M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedOct 2014 · 9 investors · BiotechnologyRule 506(b)
▶$6MraisedOct 2014 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Seth RudnickDirector
- Wayne PisanoExecutive Officer, Director
- David WilliamsDirector
- Kathleen A. McGowanExecutive Officer
- Augustine LawlorDirector
- Sam WuDirector
- Phillippe O. ChambonDirector
- Offering amount
- $6.3M
- Amount sold
- $6M
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.8MraisedFeb 2012 · 13 investors · BiotechnologyRule 506(b)
▶$24.8MraisedFeb 2012 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philippe ChambonDirector
- Alan R. ShawExecutive Officer, Director
- Augustine LawlorDirector
- David WilliamsDirector
- Sam WuDirector
- Seth RudnickDirector
- Andrew T. DrechslerExecutive Officer
- Offering amount
- $25M
- Amount sold
- $24.8M
- First sale
- Mar 2010
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Vaxinnate's investors?
- Vaxinnate's investors include Saints Capital, Canaan Partners, HealthCare Ventures, LLC.
- How much funding has Vaxinnate raised?
- Vaxinnate has disclosed $34.1M raised across 3 rounds.
- Where is Vaxinnate headquartered?
- Vaxinnate is headquartered in Cranbury, US.